Business Context and Reporting Period
This Form 8-K filing by OptimumBank Holdings, Inc. reports on events occurring on March 30, 2012, with the report filed on May 11, 2012. The filing details the closing of additional sales under a private placement offering of common stock and the issuance of shares to non-employee directors.
Key Financial Metrics and Transactions
- Private Placement Proceeds: On March 30, 2012, the company sold 4,072,000 shares at $0.40 per share, receiving net proceeds of approximately $1,629,000.
- Capital Injection: Approximately $1.4 million of the total private offering proceeds was invested in OptimumBank as additional capital.
- Director Compensation: The company issued 3,789 shares to non-employee directors for Q1 2012 board attendance fees. These shares were valued at $3.52 per share (fair market value on the issuance date).
- Offering Status: The private offering was extended through April 2, 2012, with an additional 62,500 shares sold on that date.
Material Changes and Unusual Items
The filing discloses unregistered sales of equity securities under Rule 506 of Regulation D. The March 30, 2012 transaction represented a significant closing of the ongoing private placement initiated in 2011. Notably, approximately 988,000 of the shares sold in the recent period were purchased by five earlier investors, including 500,000 shares by a company director. The filing does not provide specific revenue, profit, cash flow, or debt metrics for the period, as it focuses solely on equity transactions.
Guidance, Outlook, and Risks
The filing does not contain forward-looking guidance, management commentary on future operations, or specific risk factors beyond the standard disclosure of unregistered securities sales. The issuance of shares to directors was conducted under the 2011 Equity Incentive Plan and the Non-Employee Director Compensation Plan, which mandates 75% of fees be paid in stock and 25% in cash.
Investor Verification Checklist
- Verify the total aggregate shares sold in the private placement to date against the 37,500,000 share target mentioned in the 2011 offering.
- Confirm the exact amount of the $1.4 million capital injection into OptimumBank and its impact on the bank's regulatory capital ratios.
- Review the Investor Registration Rights Agreement referenced in the October 31, 2011 Current Report to understand future liquidity implications for these shares.
- Check the company's 10-K filed on March 30, 2012, for the full financial context of the $8.6 million in proceeds received during the fourth quarter of 2011.